CO5280204A1 - Uso de glutamina para la prevencion de la diarrea de inicio tardio inducida por irinotecan - Google Patents

Uso de glutamina para la prevencion de la diarrea de inicio tardio inducida por irinotecan

Info

Publication number
CO5280204A1
CO5280204A1 CO01002004A CO01002004A CO5280204A1 CO 5280204 A1 CO5280204 A1 CO 5280204A1 CO 01002004 A CO01002004 A CO 01002004A CO 01002004 A CO01002004 A CO 01002004A CO 5280204 A1 CO5280204 A1 CO 5280204A1
Authority
CO
Colombia
Prior art keywords
irinotecan
glutamine
prevention
diarrhea induced
late diarrhea
Prior art date
Application number
CO01002004A
Other languages
English (en)
Inventor
Diane Savarese
Original Assignee
Univ Massachusetts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts filed Critical Univ Massachusetts
Publication of CO5280204A1 publication Critical patent/CO5280204A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una composición que comprende una cantidad efectiva de glutamina para el uso en tratamiento de diarrea con inicio tardío inducida por irinotecan.
CO01002004A 2000-01-18 2001-01-12 Uso de glutamina para la prevencion de la diarrea de inicio tardio inducida por irinotecan CO5280204A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48496200A 2000-01-18 2000-01-18

Publications (1)

Publication Number Publication Date
CO5280204A1 true CO5280204A1 (es) 2003-05-30

Family

ID=23926357

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01002004A CO5280204A1 (es) 2000-01-18 2001-01-12 Uso de glutamina para la prevencion de la diarrea de inicio tardio inducida por irinotecan

Country Status (4)

Country Link
AU (1) AU2001229478A1 (es)
CO (1) CO5280204A1 (es)
PE (1) PE20011042A1 (es)
WO (1) WO2001052828A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2295429A1 (en) * 2000-01-06 2001-07-06 Michael Michael Treatment or prevention of diarrhea
WO2004103371A1 (en) * 2003-05-21 2004-12-02 Pharmacia & Upjohn Company Llc Use of cftr inhibitors for the treatment of chemotherapy-induced diarrhea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds

Also Published As

Publication number Publication date
WO2001052828A2 (en) 2001-07-26
PE20011042A1 (es) 2001-09-26
AU2001229478A1 (en) 2001-07-31
WO2001052828A3 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
AR027968A1 (es) Una composicion para utilizar en el tratamiento y/o prevencion del sarampion y el uso de dicha composicion para un vehiculo para el tratamiento o prevencion del sarampion
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
ES2422556T3 (es) Tratamiento de hepatitis vírica
HN2001000146A (es) Derivados de pirazol
MY135721A (en) Amidino compounds useful as nitric oxide synthase inhibitors
ES2196160T3 (es) Uso de una combinacion de tensioactivos, agentes quelantes y aceites esenciales para desinfeccion efectiva.
BR0316203A (pt) Uso de um agente antialérgico e um esteróide para tratar rinite alérgica
CL2004001293A1 (es) Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
BRPI0410857A (pt) método para o tratamento de depressão, uso de gaboxadol, e, composição farmacêutica
RS50682B (sr) Kombinacija kombrestatina i anti-kancer agensa
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
BR0210101A (pt) Combinações antineoplásticas
ES2184341T3 (es) Un metodo para la prevencion y el tratamiento de la disfuncion del miocardio.
BRPI0414114A (pt) uso de defibrotide, formulação, e, método para tratar um mamìfero afetado por um tumor
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
AR043327A1 (es) Uso de inhibidores de quinurenina 3- hidroxilasa para el tratamiento de la diabetes
CO5280204A1 (es) Uso de glutamina para la prevencion de la diarrea de inicio tardio inducida por irinotecan
AR028359A1 (es) Composicion para el control de artropodos
BR0111785A (pt) Composições e métodos para tratamento de candidìase
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
BR0002640A (pt) Uso de simeticona para tratar colite ulcerativa
AR031404A1 (es) Una composicion y metodo de aplicacion

Legal Events

Date Code Title Description
FA Application withdrawn